US 10414740
Glutaminase inhibitors and method of use
granted A61PA61P35/00A61P37/00
Quick answer
US patent 10414740 (Glutaminase inhibitors and method of use) held by Agios Pharmaceuticals, Inc. expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P35/00, A61P37/00